Primary Hyperoxaluria Treatment Market Size, Report | 2032

The global primary hyperoxaluria treatment market size reached a value of about USD 18.91 million in 2023 and is expected to grow at a CAGR of 3.7% during the forecast period of 2024-2032. With the growing awareness of rare disease and genetic engineering advancement, the market is expected to reach a value of about USD 26.16 million by 2032.

全球原发性草酸尿症治疗市场规模于2023年达到约1.891亿美元，预计在2024至2032年的预测期间将以3.7%的复合年增长率增长。随着罕见疾病认知度的提升及基因工程技术的进步，该市场规模预计将在2032年达到约2.616亿美元。